Results 11 to 20 of about 84,367,963 (213)

Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials

open access: yesCanadian Journal of Gastroenterology, 1989
The knowledge that 5-aminosalicylic acid (5-ASA) is the active compound of sulphasalazine and that it acts topically has stimulated the use of 5-ASA containing enemas and ocher similar compounds such as olsalazine and 4-aminosalicylic acid (4-ASA). 5-ASA
M. Campieri   +6 more
doaj   +2 more sources

Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid [PDF]

open access: yesCanadian Journal of Gastroenterology, 2009
BACKGROUND: A number of case reports link the use of 5-aminosalicylic acid (5-ASA) to interstitial nephritis in patients with inflammatory bowel disease (IBD).
Harshna Patel   +2 more
doaj   +2 more sources

Synthesis, characterization and radical scavenging activity of aromatic amine conjugates of 5-aminosalicylic acid [PDF]

open access: yesBulletin of the Chemical Society of Ethiopia, 2014
5-Aminosalicylic acid is an anti-inflammatory drug used in the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn’s disease.
K. Harveer, , S. Jasmeen
doaj   +2 more sources

Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis

open access: yesDrug Design, Development and Therapy, 2013
Jamal A Jilani,1 Maha Shomaf,2 Karem H Alzoubi3 1Department of Medicinal Chemistry and Pharmacognosy, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Pathology, Jordan University, Amman, Jordan; 3Department of Clinical Pharmacy,
Jilani JA, Shomaf M, Alzoubi KH
doaj   +1 more source

Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease

open access: yesCanadian Journal of Gastroenterology, 1999
BACKGROUND: Although 5-aminosalicylic acid (5-ASA) preparations used to treat inflammatory bowel disease are reported to have fewer side effects than sulphasalazine, increased clinical use of these compounds has resulted in increased reports of ...
Andrew W Kirkpatrick   +2 more
doaj   +2 more sources

4‑Aminosalicylic Acid Adducts

open access: yes, 2016
4-Aminosalicylic acid (p-aminosalicylic acid, PAS), an antituberculosis drug, is a model active pharmaceutical ingredient to study salt and cocrystal formation in a multiple hydrogen-bonding functionality molecule with carboxylic acid, amine, and phenol ...
Geetha Bolla (1744141)   +3 more
core   +7 more sources

Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The gut and gut microbiota, which were previously neglected in blood pressure regulation, are becoming increasingly recognized as factors contributing to hypertension. Diseases affecting the gut such as inflammatory bowel disease (IBD) present
Xue Mei   +7 more
doaj   +1 more source

Cyanidin-3-glucoside suppresses cytokine-induced inflammatory response in human intestinal cells: comparison with 5-aminosalicylic acid. [PDF]

open access: yesPLoS ONE, 2013
The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated.
Diana Serra   +4 more
doaj   +1 more source

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis [PDF]

open access: yesIntestinal Research, 2020
Background/Aims 5-Aminosalicylic acid (ASA) causes intolerance reactions in some patients. This study was performed to examine the prognosis of patients with ulcerative colitis (UC) and 5-ASA intolerance, and to evaluate the potential interaction between
Shinta Mizuno   +14 more
doaj   +1 more source

Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid

open access: yesJournal of Lipid Research, 1998
5-Aminosalicylic acid conjugate of ursodeoxycholic acid was synthesized in above 90% yield by adding a basic solution of 5-aminosalicylic acid into the mixed anhydride formed with ursodeoxycholic acid and ethyl chloroformate.
Ashok K. Batta   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy